{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:26:18Z","timestamp":1791012378042,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/bjc.2013.9","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T21:04:43Z","timestamp":1359493483000},"page":"621-628","source":"Crossref","is-referenced-by-count":34,"title":["The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma"],"prefix":"10.1038","volume":"108","author":[{"given":"D J","family":"Pinato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F A","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Casadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"issue":"8","key":"BFbjc20139_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/modpathol.3800159","volume":"17","author":"DA Arber","year":"2004","unstructured":"Arber DA, Weiss LM, West RB (2004) CD117 expression in mesothelioma. Mod Pathol 17 (8): 1021","journal-title":"Mod Pathol"},{"issue":"24","key":"BFbjc20139_CR2","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/sj.onc.1201865","volume":"16","author":"A Burchert","year":"1998","unstructured":"Burchert A, Attar EC, McCloskey P, Fridell YW, Liu ET (1998) Determinants for transformation induced by the Axl receptor tyrosine kinase. Oncogene 16 (24): 3177\u20133187","journal-title":"Oncogene"},{"issue":"1","key":"BFbjc20139_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","volume":"77","author":"S Cedres","year":"2012","unstructured":"Cedres S, Montero MA, Martinez P, Martinez A, Rodriguez-Freixinos V, Torrejon D, Gabaldon A, Salcedo M, Ramon YCS, Felip E (2012) Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM). Lung Cancer 77 (1): 192\u2013198","journal-title":"Lung Cancer"},{"issue":"2","key":"BFbjc20139_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","volume":"51","author":"A Destro","year":"2006","unstructured":"Destro A, Ceresoli GL, Falleni M, Zucali PA, Morenghi E, Bianchi P, Pellegrini C, Cordani N, Vaira V, Alloisio M, Rizzi A, Bosari S, Roncalli M (2006) EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations. Lung Cancer 51 (2): 207\u2013215","journal-title":"Lung Cancer"},{"issue":"3","key":"BFbjc20139_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.lungcan.2006.08.012","volume":"54","author":"JG Edwards","year":"2006","unstructured":"Edwards JG, Swinson DE, Jones JL, Waller DA, O'Byrne KJ (2006) EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma. Lung Cancer 54 (3): 399\u2013407","journal-title":"Lung Cancer"},{"issue":"1","key":"BFbjc20139_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1200\/JCO.2005.07.050","volume":"23","author":"DA Fennell","year":"2005","unstructured":"Fennell DA, Parmar A, Shamash J, Evans MT, Sheaff MT, Sylvester R, Dhaliwal K, Gower N, Steele J, Rudd R (2005) Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol 23 (1): 184\u2013189","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc20139_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1128\/MCB.16.1.135","volume":"16","author":"YW Fridell","year":"1996","unstructured":"Fridell YW, Jin Y, Quilliam LA, Burchert A, McCloskey P, Spizz G, Varnum B, Der C, Liu ET (1996) Differential activation of the Ras\/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol Cell Biol 16 (1): 135\u2013145","journal-title":"Mol Cell Biol"},{"issue":"17","key":"BFbjc20139_CR8","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","volume":"25","author":"LL Garland","year":"2007","unstructured":"Garland LL, Rankin C, Gandara DR, Rivkin SE, Scott KM, Nagle RB, Klein-Szanto AJ, Testa JR, Altomare DA, Borden EC (2007) Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol 25 (17): 2406\u20132413","journal-title":"J Clin Oncol"},{"issue":"3","key":"BFbjc20139_CR9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.0909333107","volume":"107","author":"C Gjerdrum","year":"2010","unstructured":"Gjerdrum C, Tiron C, Hoiby T, Stefansson I, Haugen H, Sandal T, Collett K, Li S, McCormack E, Gjertsen BT, Micklem DR, Akslen LA, Glackin C, Lorens JB (2010) Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci USA 107 (3): 1124\u20131129","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"BFbjc20139_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF03256303","volume":"12","author":"L Greillier","year":"2008","unstructured":"Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A (2008) Biomarkers for malignant pleural mesothelioma: current status. Mol Diagn Ther 12 (6): 375\u2013390","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"BFbjc20139_CR11","doi-asserted-by":"publisher","first-page":"H1207","DOI":"10.1152\/ajpheart.00020.2004","volume":"287","author":"I Hasanbasic","year":"2004","unstructured":"Hasanbasic I, Cuerquis J, Varnum B, Blostein MD (2004) Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol 287 (3): H1207\u2013H1213","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"BFbjc20139_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/JTO.0b013e3181ae25bf","volume":"4","author":"A Hasani","year":"2009","unstructured":"Hasani A, Alvarez JM, Wyatt JM, Bydder S, Millward M, Byrne M, Musk AW, Nowak AK (2009) Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia. J Thorac Oncol 4 (8): 1010\u20131016","journal-title":"J Thorac Oncol"},{"issue":"20","key":"BFbjc20139_CR13","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1158\/0008-5472.CAN-05-0993","volume":"65","author":"SJ Holland","year":"2005","unstructured":"Holland SJ, Powell MJ, Franci C, Chan EW, Friera AM, Atchison RE, McLaughlin J, Swift SE, Pali ES, Yam G, Wong S, Lasaga J, Shen MR, Yu S, Xu W, Hitoshi Y, Bogenberger J, Nor JE, Payan DG, Lorens JB (2005) Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res 65 (20): 9294\u20139303","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc20139_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/1078-0432.CCR-07-0862","volume":"14","author":"M Hutterer","year":"2008","unstructured":"Hutterer M, Knyazev P, Abate A, Reschke M, Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, Kostron H, Stockhammer G, Ullrich A (2008) Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 14 (1): 130\u2013138","journal-title":"Clin Cancer Res"},{"issue":"3","key":"BFbjc20139_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","volume":"136","author":"D Jean","year":"2012","unstructured":"Jean D, Daubriac J, Le Pimpec-Barthes F, Galateau-Salle F, Jaurand MC (2012) Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch Pathol Lab Med 136 (3): 277\u2013293","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"BFbjc20139_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10549-011-1835-1","volume":"133","author":"CE Johnson","year":"2012","unstructured":"Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG (2012) Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Breast Cancer Res Treat 133 (3): 889\u2013898","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"BFbjc20139_CR17","first-page":"179","volume":"17","author":"TK Joshi","year":"2004","unstructured":"Joshi TK, Gupta RK (2004) Asbestos in developing countries: magnitude of risk and its practical implications. Int J Occup Med Environ Health 17 (1): 179\u2013185","journal-title":"Int J Occup Med Environ Health"},{"issue":"23","key":"BFbjc20139_CR18","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ (2010) High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 16 (23): 5805\u20135813","journal-title":"Clin Cancer Res"},{"issue":"1","key":"BFbjc20139_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cllc.2012.03.011","volume":"14","author":"SC Kao","year":"2012","unstructured":"Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S (2012) Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clin Lung Cancer 14 (1): 70\u201377","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"BFbjc20139_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/JTO.0b013e3182417da5","volume":"7","author":"G Levallet","year":"2012","unstructured":"Levallet G, Vaisse-Lesteven M, Le Stang N, Ilg AG, Brochard P, Astoul P, Pairon JC, Bergot E, Zalcman G, Galateau-Salle F (2012) Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group. J Thorac Oncol 7 (3): 599\u2013606","journal-title":"J Thorac Oncol"},{"issue":"11","key":"BFbjc20139_CR21","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1182\/blood-2009-06-228684","volume":"115","author":"S Loges","year":"2010","unstructured":"Loges S, Schmidt T, Tjwa M, van Geyte K, Lievens D, Lutgens E, Vanhoutte D, Borgel D, Plaisance S, Hoylaerts M, Luttun A, Dewerchin M, Jonckx B, Carmeliet P (2010) Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6. Blood 115 (11): 2264\u20132273","journal-title":"Blood"},{"issue":"2","key":"BFbjc20139_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ccr.2008.06.002","volume":"14","author":"PK Majumder","year":"2008","unstructured":"Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M, Sellers WR (2008) A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell 14 (2): 146\u2013155","journal-title":"Cancer Cell"},{"issue":"15","key":"BFbjc20139_CR23","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.4161\/cc.6.15.4516","volume":"6","author":"FA Mallette","year":"2007","unstructured":"Mallette FA, Ferbeyre G (2007) The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 6 (15): 1831\u20131836","journal-title":"Cell Cycle"},{"issue":"1","key":"BFbjc20139_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.lungcan.2005.04.010","volume":"50","author":"A Mathy","year":"2005","unstructured":"Mathy A, Baas P, Dalesio O, van Zandwijk N (2005) Limited efficacy of imatinib mesylate in malignant mesothelioma: a phase II trial. Lung Cancer 50 (1): 83\u201386","journal-title":"Lung Cancer"},{"issue":"14","key":"BFbjc20139_CR25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/onc.2010.555","volume":"30","author":"WB Ou","year":"2011","unstructured":"Ou WB, Corson JM, Flynn DL, Lu WP, Wise SC, Bueno R, Sugarbaker DJ, Fletcher JA (2011a) AXL regulates mesothelioma proliferation and invasiveness. Oncogene 30 (14): 1643\u20131652","journal-title":"Oncogene"},{"issue":"1","key":"BFbjc20139_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1593\/neo.101156","volume":"13","author":"WB Ou","year":"2011","unstructured":"Ou WB, Hubert C, Corson JM, Bueno R, Flynn DL, Sugarbaker DJ, Fletcher JA (2011b) Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma. Neoplasia 13 (1): 12\u201322","journal-title":"Neoplasia"},{"issue":"3","key":"BFbjc20139_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","volume":"7","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R (2012) Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol 7 (3): 587\u2013594","journal-title":"J Thorac Oncol"},{"issue":"1","key":"BFbjc20139_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lungcan.2011.12.009","volume":"77","author":"O Rena","year":"2012","unstructured":"Rena O, Casadio C (2012) Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer 77 (1): 151\u2013155","journal-title":"Lung Cancer"},{"issue":"7","key":"BFbjc20139_CR29","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/emboj.2012.21","volume":"31","author":"GX Ruan","year":"2012","unstructured":"Ruan GX, Kazlauskas A (2012) Axl is essential for VEGF-A-dependent activation of PI3K\/Akt. EMBO J 31 (7): 1692\u20131703","journal-title":"EMBO J"},{"issue":"4","key":"BFbjc20139_CR30","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","volume":"108","author":"VW Rusch","year":"1995","unstructured":"Rusch VW (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108 (4): 1122\u20131128","journal-title":"Chest"},{"issue":"5","key":"BFbjc20139_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ncb1567","volume":"9","author":"CJ Sarkisian","year":"2007","unstructured":"Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9 (5): 493\u2013505","journal-title":"Nat Cell Biol"},{"issue":"6","key":"BFbjc20139_CR32","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/39.6.1709656","volume":"39","author":"SR Shi","year":"1991","unstructured":"Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39 (6): 741\u2013748","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"BFbjc20139_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/cncr.25483","volume":"117","author":"X Song","year":"2011","unstructured":"Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB (2011) Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117 (4): 734\u2013743","journal-title":"Cancer"},{"issue":"8","key":"BFbjc20139_CR34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, Snee M, O'Brien M, Thomas G, Senan S, O\u2019Byrne K, Kilburn LS, Spicer J, Landau D, Edwards J, Coombes G, Darlison L, Peto J (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12 (8): 763\u2013772","journal-title":"Lancet Oncol"},{"issue":"14","key":"BFbjc20139_CR35","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (14): 2636\u20132644","journal-title":"J Clin Oncol"},{"issue":"12","key":"BFbjc20139_CR36","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/onc.2010.509","volume":"30","author":"K Vuoriluoto","year":"2011","unstructured":"Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30 (12): 1436\u20131448","journal-title":"Oncogene"},{"issue":"7","key":"BFbjc20139_CR37","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","volume":"18","author":"W Weder","year":"2007","unstructured":"Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R, Ris HB, Jermann M, Mingrone W, Roth AD, Spiliopoulos A (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (7): 1196\u20131202","journal-title":"Ann Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc20139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:21:34Z","timestamp":1684416094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc20139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFbjc20139"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}